Identity
- Trade Name
- WinSlate FDA UDI
- Generic Name
- Voice synthesizer/digitizer FDA UDI
- Device Name
- WinSlate for Kids Speech Generating Device FDA UDI
- Model / Reference
- WinSlate for Kids FDA UDI
- Description
- WinSlate for Kids Speech Generating Device FDA UDI
Identifiers
- Primary DI / UDI-DI
- B398WSKD0 FDA UDI
- FDA Product Code
- ILQ FDA UDI
- GMDN Term
- Voice synthesizer/digitizer FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 890.3710 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
No
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
No
FDA UDI
Over-the-Counter
Yes
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
Yes
FDA UDI
Lot / Batch Number
No
FDA UDI
Serial Number
Yes
FDA UDI
Expiration Date
No
FDA UDI
Manufacturing Date
No
FDA UDI
Category: Voice synthesizer/digitizer
WinSlate by Forbes Rehab Services Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Voice synthesizer/digitizer.
- Lingraphica — LINGRAPHICARE AMERICA, INC. · Class II
- Chat Fusion — PRENTKE ROMICH COMPANY · Class II
- Nova Chat — PRENTKE ROMICH COMPANY · Class II
- G13 — SMARTBOX ASSISTIVE TECHNOLOGY INC · Class II
- Nova Chat — PRENTKE ROMICH COMPANY · Class II
- Chat Fusion — PRENTKE ROMICH COMPANY · Class II
- PRC Look™ — PRENTKE ROMICH COMPANY · Class II
- Touch Chat — PRENTKE ROMICH COMPANY · Class II
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Forbes Rehab Services Inc.
Sources (1)
- FDA UDI 3bbc656a-627d-4085-b3a0-0b5badd856e2 34 fields · synced May 30, 2026